首页|期刊导航|Journal of Interventional Medicine|Validation of the CRAFITY score for predicting prognosis in patients with hepatocellular carcinoma undergoing transarterial chemoembolization combined with systemic therapy
Validation of the CRAFITY score for predicting prognosis in patients with hepatocellular carcinoma undergoing transarterial chemoembolization combined with systemic therapy
Haifeng Zhou Jianwu Ren Feida Wu Wei Yang Di Zhu Yuguan Xie Qi Shi Zhongling Pei Yan Shen Lingling Wu Sheng Liu Haibin Shi Weizhong Zhou
Journal of Interventional Medicine2025，Vol.7Issue(1)：P.3-9,7.
Journal of Interventional Medicine2025，Vol.7Issue(1)：P.3-9,7.DOI:10.1016/j.jimed.2023.12.004
Validation of the CRAFITY score for predicting prognosis in patients with hepatocellular carcinoma undergoing transarterial chemoembolization combined with systemic therapy
摘要
关键词
Transarterial chemoembolization/Hepatocellular carcinoma/Prognosis prediction/Tyrosine kinase inhibitor/Immune checkpoint inhibitor分类
医药卫生引用本文复制引用
Haifeng Zhou,Jianwu Ren,Feida Wu,Wei Yang,Di Zhu,Yuguan Xie,Qi Shi,Zhongling Pei,Yan Shen,Lingling Wu,Sheng Liu,Haibin Shi,Weizhong Zhou..Validation of the CRAFITY score for predicting prognosis in patients with hepatocellular carcinoma undergoing transarterial chemoembolization combined with systemic therapy[J].Journal of Interventional Medicine,2025,7(1):P.3-9,7.基金项目
supported by the Jiangsu Provincial Innovative and Entrepreneurial Doctor Program(303073543ER21)to Haifeng Zhou （303073543ER21）
the National Natural Science Foundation of China(81701802)to Weizhong Zhou and the Jiangsu Province Capability Improvement Project through Science （81701802）
Technology and Education(JSDW202243)to Haibin Shi.The funders had no role in study design,data collection and analysis,decision to publish,or preparation of the manuscript. （JSDW202243）
